Synonyms Refractory Richter Syndrome, Refractory Transformed Chronic Lymphocytic Leukemia |
Introduction Chronic lymphocytic leukemia which has undergone histologic transformation to an aggressive diffuse large B-cell lymphoma (Richter's transformation) and has become resistant to treatment. |
Target |
Mechanism CD19 modulators [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date05 Feb 2021 |
Target |
Mechanism Bcl-2 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CD19 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 1/2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Jun 2024 |
Sponsor / Collaborator |
Start Date29 Mar 2024 |
Sponsor / Collaborator |
Start Date02 Jan 2024 |
Sponsor / Collaborator |